Intelligence - PMLiVE
WEBOptimizing Patient Recruitment & Retention in Influenza Studies. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase.
About us - PMLiVE
WEBThe PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly print title Comm uniqué are published by PMGroup. They offer the latest pharma news, analysis, jobs and events, including the annual Pharmaceutical Market Excellence Awards (PMEAs) and Comm uniqué Awards.
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBWith the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase. Addressing these challenges early is crucial to the success of the studies.
Pfizer and BioNTech share late-stage results for COVID-19/flu ...
WEBAug 16, 2024 · Pfizer and BioNTech have announced top-line results from a late-stage study of their mRNA-based combination vaccine for influenza and COVID-19. The partners have been evaluating the candidate against a licensed flu vaccine and their own licensed COVID-19 vaccine given at the same visit in more …
Research - PMLiVE
WEBMore than 100,640 cases of the skin cancer are expected to be diagnosed in the US this year. Common antidiabetic drug metformin found to slow growth of precancerous cells. The findings suggest that the drug could be used to manage squamous oesophageal cancer risk. Sanofi/Regeneron announce positive late-stage results for Dupixent in chronic ...
PME - PMLiVE
WEBPharmaceutical Market Europe – October 2023. Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments.
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBOptimizing Patient Recruitment & Retention in Influenza Studies. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase.
Moderna shares positive late-stage results for COVID-19/flu …
WEBJun 11, 2024 · Moderna has shared positive late-stage results for its investigational combination vaccine against influenza and COVID-19.
White Papers and Resources - PMLiVE
WEBSep 6, 2024 · Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or …
Communique - PMLiVE
WEBCommuniqué – Volume 53. New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change.